New trends in bioactive scaffolds: The importance of nanostructure

Abstract There are many criteria for an ideal scaffold that will stimulate the body's repair mechanisms to regenerate diseased or damaged bone to its original healthy state. These include having a pore network large and open enough for cells and blood vessels to penetrate and the ability to bond to bone. Sol–gel derived bioactive glasses have a nanoporosity that can control degradation rate. They can be foamed to produce scaffolds that mimic cancellous bone macrostructure. Bioactive glass foams with optimised nanoporosity are strong in compression; however, they have low toughness and pore strength when loaded in tension. Therefore an ideal scaffold would have all the properties of the glasses with enhanced toughness. This can only be achieved by creating new nanoscale composites. Resorbable polymers must interact with the silica based inorganic network at the nanoscale to maintain bioactivity and controlled resorption. This is a complex problem but may be the future of scaffold development.

[1]  H. Oonishi,et al.  Quantitative comparison of bone growth behavior in granules of Bioglass, A-W glass-ceramic, and hydroxyapatite. , 2000, Journal of biomedical materials research.

[2]  L. Hench,et al.  Surface-modified 3D scaffolds for tissue engineering , 2002, Journal of materials science. Materials in medicine.

[3]  L L Hench,et al.  Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. , 2001, Journal of biomedical materials research.

[4]  Dominique Bernard,et al.  Non-destructive quantitative 3D analysis for the optimisation of tissue scaffolds. , 2007, Biomaterials.

[5]  Larry L. Hench,et al.  The story of Bioglass® , 2006, Journal of materials science. Materials in medicine.

[6]  C. Perry,et al.  Comparative study of the in vitro apatite-forming ability of poly(epsilon-caprolactone)-silica sol-gels using three osteoconductivity tests (static, dynamic, and alternate soaking process). , 2004, Journal of biomedical materials research. Part A.

[7]  P. Revell.  Pathology of Bone , 1985 .

[8]  S. Rhee.  Bone-like apatite-forming ability and mechanical properties of poly(ε-caprolactone)/silica hybrid as a function of poly(ε-caprolactone) content , 2004 .

[9]  B. Lim,et al.  Comparative in vitro and in vivo studies using a bioactive poly(epsilon-caprolactone)-organosiloxane nanohybrid containing calcium salt. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[10]  María Vallet-Regí,et al.  Bioactive Star Gels , 2006 .

[11]  L. Hench,et al.  The sol-gel process , 1990 .

[12]  M. Vallet‐Regí,et al.  Bioceramics and pharmaceuticals: A remarkable synergy , 2007 .

[13]  Hyoun‐Ee Kim,et al.  Bioactive glass nanofiber-collagen nanocomposite as a novel bone regeneration matrix. , 2006, Journal of biomedical materials research. Part A.

[14]  S. Rhee,et al.  Effect of acidic degradation products of poly(lactic-co-glycolic)acid on the apatite-forming ability of poly(lactic-co-glycolic)acid-siloxane nanohybrid material. , 2007, Journal of biomedical materials research. Part A.

[15]  L. Ren,et al.  Synthesis and Characterization of Gelatin-Siloxane Hybrids Derived through Sol-Gel Procedure , 2001 .

[16]  N. Chayen,et al.  Experiment and theory for heterogeneous nucleation of protein crystals in a porous medium. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S F Hulbert,et al.  Tissue reaction to three ceramics of porous and non-porous structures. , 1972, Journal of biomedical materials research.

[18]  L. Ren,et al.  In vitro Evaluation of Osteoblast Response to Sol-Gel Derived Gelatin-Siloxane Hybrids , 2003 .

[19]  Suming Li,et al.  Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.

[20]  Julian R. Jones,et al.  Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. , 2004, Biomaterials.

[21]  R. Legeros,et al.  Properties of osteoconductive biomaterials: calcium phosphates. , 2002, Clinical orthopaedics and related research.

[22]  Julian R. Jones,et al.  Effect of surfactant concentration and composition on the structure and properties of sol-gel-derived bioactive glass foam scaffolds for tissue engineering , 2003 .

[23]  L. Hench,et al.  Mechanisms of hydroxyapatite formation on porous gel-silica substrates , 1996 .

[24]  L. Hench,et al.  Preparation of bioactive glass-polyvinyl alcohol hybrid foams by the sol-gel method , 2005, Journal of materials science. Materials in medicine.

[25]  Julian R. Jones,et al.  Bioactive glass and hybrid scaffolds prepared by sol–gel method for bone tissue engineering , 2005 .

[26]  L L Hench,et al.  In vitro dissolution of melt-derived 45S5 and sol-gel derived 58S bioactive glasses. , 2002, Journal of biomedical materials research.

[27]  Julian R Jones,et al.  Bioactive sol-gel foams for tissue repair. , 2002, Journal of biomedical materials research.

[28]  Jian Shen,et al.  Covalent immobilization of O-butyrylchitosan with a photosensitive hetero-bifunctional crosslinking reagent on biopolymer substrate surface and bloodcompatibility characterization , 2003, Journal of biomaterials science. Polymer edition.

[29]  L. Hench,et al.  Mesoporous calcium silicate glasses. I. Synthesis , 2003 .

[30]  Larry L. Hench,et al.  Bonding mechanisms at the interface of ceramic prosthetic materials , 1971 .

[31]  C. D. W. Wilkinson,et al.  The effects of nanoscale pits on primary human osteoblast adhesion formation and cellular spreading , 2007, Journal of materials science. Materials in medicine.

[32]  A R Boccaccini,et al.  Mechanical properties of highly porous PDLLA/Bioglass composite foams as scaffolds for bone tissue engineering. , 2005, Acta biomaterialia.

[33]  B. Lim,et al.  Evaluation of a novel poly(epsilon-caprolactone)-organosiloxane hybrid material for the potential application as a bioactive and degradable bone substitute. , 2004, Biomacromolecules.

[34]  Julian H. George,et al.  Exploring and Engineering the Cell Surface Interface , 2005, Science.

[35]  Larry L. Hench,et al.  Analysis of pore interconnectivity in bioactive glass foams using X-ray microtomography , 2004 .

[36]  María Vallet-Regí,et al.  From the bioactive glasses to the star gels , 2006, Journal of materials science. Materials in medicine.

[37]  S. Blacher,et al.  Biodegradable and Biocompatible Inorganic−Organic Hybrid Materials. 3. A Valuable Route to the Control of the Silica Porosity , 1998 .

[38]  R. Langer,et al.  Designing materials for biology and medicine , 2004, Nature.

[39]  Julian R Jones,et al.  Optimising bioactive glass scaffolds for bone tissue engineering. , 2006, Biomaterials.

[40]  M. Vallet‐Regí,et al.  A bioactive sol‐gel glass implant for in vivo gentamicin release. Experimental model in Rabbit , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[41]  Kanji Tsuru,et al.  Novel approach to fabricate porous gelatin-siloxane hybrids for bone tissue engineering. , 2002, Biomaterials.

[42]  Julian R. Jones,et al.  Extracellular matrix formation and mineralization on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells. , 2007, Biomaterials.

[43]  L. Hench,et al.  In vitro release kinetics of proteins from bioactive foams. , 2003, Journal of biomedical materials research. Part A.

[44]  A. R. Boccaccini,et al.  The surface functionalization of 45S5 Bioglass®-based glass-ceramic scaffolds and its impact on bioactivity , 2006, Journal of materials science. Materials in medicine.

[45]  Larry L Hench,et al.  Third-Generation Biomedical Materials , 2002, Science.